FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043016821> ?p ?o ?g. }

• W3043016821 abstract "Abstract Background There is limited evidence that rituximab, a B cell depletion therapy, is an effective treatment for systemic lupus erythematosus (SLE). Data on the mechanisms of B cell depletion in SLE indicate that the combination of rituximab and belimumab may be more effective than rituximab alone. The safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial aims to determine whether belimumab is superior to placebo, when given 4–8 weeks after treatment with rituximab. This article describes the statistical analysis plan for this trial as an update to the published protocol. It is written prior to the end of patient follow-up, while the outcome of the trial is still unknown. Design and methods BEAT-LUPUS is a randomised, double-blind, phase II trial of 52 weeks of belimumab versus placebo, initiated 4–8 weeks after rituximab treatment. The primary outcome is anti-dsDNA antibodies at 52 weeks post randomisation. Secondary outcomes include lupus flares and damage, adverse events, doses of concomitant medications, quality of life, and clinical biomarkers. We describe the trial’s clinical context, outcome measures, sample size calculation, and statistical modelling strategy, and the supportive analyses planned to evaluate for mediation of the treatment effect through changes in concomitant medication doses and bias from missing data. Discussion The analysis will provide detailed information on the safety and effectiveness of belimumab. It will be implemented from July 2020 when patient follow-up and data collection is complete. Trial registration ISRCTN: 47873003 . Registered on 28 November 2016. EudracT: 2015-005543-14 . Registered on 19 November 2018." @default.
• W3043016821 created "2020-07-23" @default.
• W3043016821 creator A5028842875 @default.
• W3043016821 creator A5034519980 @default.
• W3043016821 creator A5042283831 @default.
• W3043016821 creator A5050093551 @default.
• W3043016821 creator A5067573670 @default.
• W3043016821 date "2020-07-16" @default.
• W3043016821 modified "2023-09-26" @default.
• W3043016821 title "Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan" @default.
• W3043016821 cites W1535600844 @default.
• W3043016821 cites W1606361567 @default.
• W3043016821 cites W1972132706 @default.
• W3043016821 cites W1977815054 @default.
• W3043016821 cites W1990166011 @default.
• W3043016821 cites W2010143351 @default.
• W3043016821 cites W2022070992 @default.
• W3043016821 cites W2053692867 @default.
• W3043016821 cites W2064999867 @default.
• W3043016821 cites W2103509618 @default.
• W3043016821 cites W2108905161 @default.
• W3043016821 cites W2113844939 @default.
• W3043016821 cites W2128797520 @default.
• W3043016821 cites W2133494987 @default.
• W3043016821 cites W2135252441 @default.
• W3043016821 cites W2148083007 @default.
• W3043016821 cites W2151628746 @default.
• W3043016821 cites W2155573955 @default.
• W3043016821 cites W2156489607 @default.
• W3043016821 cites W2483159976 @default.
• W3043016821 cites W2604323556 @default.
• W3043016821 cites W2994999044 @default.
• W3043016821 cites W4236805817 @default.
• W3043016821 doi "https://doi.org/10.1186/s13063-020-04391-2" @default.
• W3043016821 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7364494" @default.
• W3043016821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32677992" @default.
• W3043016821 hasPublicationYear "2020" @default.
• W3043016821 type Work @default.
• W3043016821 sameAs 3043016821 @default.
• W3043016821 citedByCount "4" @default.
• W3043016821 countsByYear W30430168212021 @default.
• W3043016821 countsByYear W30430168212022 @default.
• W3043016821 crossrefType "journal-article" @default.
• W3043016821 hasAuthorship W3043016821A5028842875 @default.
• W3043016821 hasAuthorship W3043016821A5034519980 @default.
• W3043016821 hasAuthorship W3043016821A5042283831 @default.
• W3043016821 hasAuthorship W3043016821A5050093551 @default.
• W3043016821 hasAuthorship W3043016821A5067573670 @default.
• W3043016821 hasBestOaLocation W30430168211 @default.
• W3043016821 hasConcept C126322002 @default.
• W3043016821 hasConcept C142724271 @default.
• W3043016821 hasConcept C159654299 @default.
• W3043016821 hasConcept C168563851 @default.
• W3043016821 hasConcept C170286685 @default.
• W3043016821 hasConcept C1862650 @default.
• W3043016821 hasConcept C197934379 @default.
• W3043016821 hasConcept C203014093 @default.
• W3043016821 hasConcept C204787440 @default.
• W3043016821 hasConcept C27081682 @default.
• W3043016821 hasConcept C2776912625 @default.
• W3043016821 hasConcept C2778453870 @default.
• W3043016821 hasConcept C2779134260 @default.
• W3043016821 hasConcept C2779338263 @default.
• W3043016821 hasConcept C2779384505 @default.
• W3043016821 hasConcept C2780653079 @default.
• W3043016821 hasConcept C2781205201 @default.
• W3043016821 hasConcept C535046627 @default.
• W3043016821 hasConcept C71924100 @default.
• W3043016821 hasConceptScore W3043016821C126322002 @default.
• W3043016821 hasConceptScore W3043016821C142724271 @default.
• W3043016821 hasConceptScore W3043016821C159654299 @default.
• W3043016821 hasConceptScore W3043016821C168563851 @default.
• W3043016821 hasConceptScore W3043016821C170286685 @default.
• W3043016821 hasConceptScore W3043016821C1862650 @default.
• W3043016821 hasConceptScore W3043016821C197934379 @default.
• W3043016821 hasConceptScore W3043016821C203014093 @default.
• W3043016821 hasConceptScore W3043016821C204787440 @default.
• W3043016821 hasConceptScore W3043016821C27081682 @default.
• W3043016821 hasConceptScore W3043016821C2776912625 @default.
• W3043016821 hasConceptScore W3043016821C2778453870 @default.
• W3043016821 hasConceptScore W3043016821C2779134260 @default.
• W3043016821 hasConceptScore W3043016821C2779338263 @default.
• W3043016821 hasConceptScore W3043016821C2779384505 @default.
• W3043016821 hasConceptScore W3043016821C2780653079 @default.
• W3043016821 hasConceptScore W3043016821C2781205201 @default.
• W3043016821 hasConceptScore W3043016821C535046627 @default.
• W3043016821 hasConceptScore W3043016821C71924100 @default.
• W3043016821 hasFunder F4320307773 @default.
• W3043016821 hasFunder F4320327444 @default.
• W3043016821 hasFunder F4320335827 @default.
• W3043016821 hasIssue "1" @default.
• W3043016821 hasLocation W30430168211 @default.
• W3043016821 hasLocation W30430168212 @default.
• W3043016821 hasLocation W30430168213 @default.
• W3043016821 hasLocation W30430168214 @default.
• W3043016821 hasLocation W30430168215 @default.
• W3043016821 hasLocation W30430168216 @default.
• W3043016821 hasLocation W30430168217 @default.
• W3043016821 hasOpenAccess W3043016821 @default.
• W3043016821 hasPrimaryLocation W30430168211 @default.

• next